Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1982 2
1983 2
1984 3
1985 1
1986 2
1987 1
1988 2
1989 2
1990 2
1991 2
1992 1
1993 4
1994 2
1995 5
1996 1
1997 3
1998 1
1999 4
2000 7
2001 2
2002 3
2003 5
2004 2
2005 6
2006 6
2007 3
2008 1
2009 4
2010 5
2011 5
2012 2
2013 4
2014 1
2015 2
2016 5
2017 3
2018 3
2019 12
2020 42
2021 23
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Effects of rituximab therapy on B cell differentiation and depletion.
Bergantini L, d'Alessandro M, Cameli P, Vietri L, Vagaggini C, Perrone A, Sestini P, Frediani B, Bargagli E. Bergantini L, et al. Among authors: sestini p. Clin Rheumatol. 2020 May;39(5):1415-1421. doi: 10.1007/s10067-020-04996-7. Epub 2020 Feb 22. Clin Rheumatol. 2020. PMID: 32088800 Review.
Pulmonary lymphatic vessel morphology: a review.
Weber E, Sozio F, Borghini A, Sestini P, Renzoni E. Weber E, et al. Among authors: sestini p. Ann Anat. 2018 Jul;218:110-117. doi: 10.1016/j.aanat.2018.02.011. Epub 2018 Apr 19. Ann Anat. 2018. PMID: 29679722 Review.
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis.
D'Alessandro M, Bergantini L, Cameli P, Landi C, Lanzarone N, Perrone A, Alonzi V, Perillo F, Bianchi F, Metella Refini R, Pieroni M, Sestini P, Bargagli E. D'Alessandro M, et al. Among authors: sestini p. Panminerva Med. 2022 Dec;64(4):548-554. doi: 10.23736/S0031-0808.20.04056-2. Epub 2020 Dec 4. Panminerva Med. 2022. PMID: 33274906 Review.
Serum amyloid A: A potential biomarker of lung disorders.
Vietri L, Fui A, Bergantini L, d'Alessandro M, Cameli P, Sestini P, Rottoli P, Bargagli E. Vietri L, et al. Among authors: sestini p. Respir Investig. 2020 Jan;58(1):21-27. doi: 10.1016/j.resinv.2019.09.005. Epub 2019 Nov 8. Respir Investig. 2020. PMID: 31708467 Review.
Home oxygen therapy: re-thinking the role of devices.
Melani AS, Sestini P, Rottoli P. Melani AS, et al. Among authors: sestini p. Expert Rev Clin Pharmacol. 2018 Mar;11(3):279-289. doi: 10.1080/17512433.2018.1421457. Epub 2018 Jan 4. Expert Rev Clin Pharmacol. 2018. PMID: 29272974 Review.
Clinical phenotyping in sarcoidosis management.
Rana GD, d'Alessandro M, Rizzi L, Bergantini L, Cameli P, Vozza A, Sestini P, Suppressa P, Bargagli E. Rana GD, et al. Among authors: sestini p. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021007. doi: 10.36141/svdld.v38i2.10423. Epub 2021 Jun 28. Sarcoidosis Vasc Diffuse Lung Dis. 2021. PMID: 34316252 Free PMC article.
Prognostic role of KL-6 in lymphangioleiomyomatosis patients.
D'Alessandro M, Bergantini L, Cameli P, Perillo F, Remediani L, Refini RM, Pieroni M, Mazzei MA, Sestini P, Bargagli E. D'Alessandro M, et al. Among authors: sestini p. Minerva Med. 2022 Aug;113(4):727-729. doi: 10.23736/S0026-4806.21.07322-5. Epub 2021 Feb 12. Minerva Med. 2022. PMID: 33576198 No abstract available.
Immunologic responses to antifibrotic treatment in IPF patients.
d'Alessandro M, Bergantini L, Cameli P, Fanetti M, Alderighi L, Armati M, Refini RM, Alonzi V, Sestini P, Bargagli E. d'Alessandro M, et al. Among authors: sestini p. Int Immunopharmacol. 2021 Jun;95:107525. doi: 10.1016/j.intimp.2021.107525. Epub 2021 Mar 11. Int Immunopharmacol. 2021. PMID: 33714885
179 results